F&V Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.91M | Buy |
170,971
+250
| +0.1% | +$11.6K | 2.02% | 25 |
|
|
2025
Q1 | $10.4M | Sell |
170,721
-1,437
| -0.8% | -$87.6K | 2.7% | 20 |
|
|
2024
Q4 | $9.74M | Buy |
172,158
+1,600
| +0.9% | +$90.5K | 2.56% | 21 |
|
|
2024
Q3 | $8.83M | Buy |
170,558
+3,070
| +2% | +$159K | 2.27% | 24 |
|
|
2024
Q2 | $6.96M | Buy |
167,488
+9,180
| +6% | +$381K | 2.03% | 24 |
|
|
2024
Q1 | $8.59M | Buy |
158,308
+4,485
| +3% | +$243K | 2.53% | 21 |
|
|
2023
Q4 | $7.89M | Buy |
153,823
+220
| +0.1% | +$11.3K | 2.53% | 22 |
|
|
2023
Q3 | $8.92M | Sell |
153,603
-1,865
| -1% | -$108K | 3.06% | 14 |
|
|
2023
Q2 | $9.94M | Sell |
155,468
-1,630
| -1% | -$104K | 3.21% | 12 |
|
|
2023
Q1 | $10.9M | Buy |
157,098
+6,755
| +4% | +$468K | 3.61% | 12 |
|
|
2022
Q4 | $10.8M | Buy |
150,343
+250
| +0.2% | +$18K | 3.6% | 12 |
|
|
2022
Q3 | $10.7M | Buy |
150,093
+2,700
| +2% | +$192K | 4.12% | 6 |
|
|
2022
Q2 | $11.3M | Buy |
147,393
+5,285
| +4% | +$407K | 4.04% | 7 |
|
|
2022
Q1 | $10.4M | Buy |
142,108
+150
| +0.1% | +$11K | 3.15% | 13 |
|
|
2021
Q4 | $8.85M | Buy |
141,958
+12,405
| +10% | +$773K | 2.97% | 20 |
|
|
2021
Q3 | $7.67M | Buy |
129,553
+1,955
| +2% | +$116K | 3.07% | 19 |
|
|
2021
Q2 | $8.53M | Buy |
127,598
+47,173
| +59% | +$3.15M | 3.13% | 16 |
|
|
2021
Q1 | $5.08M | Buy |
80,425
+73,121
| +1,001% | +$4.62M | 1.9% | 27 |
|
|
2020
Q4 | $453K | Buy |
7,304
+3,975
| +119% | +$247K | 0.2% | 51 |
|
|
2020
Q3 | $201K | Buy |
+3,329
| New | +$201K | 0.1% | 58 |
|
|
2020
Q1 | – | Sell |
-3,429
| Closed | -$220K | – | 66 |
|
|
2019
Q4 | $220K | Buy |
+3,429
| New | +$220K | 0.12% | 56 |
|